







Maru - Pediatric Nebulizer
Medical Device - Pediatric Nebulizer
AstraZeneca
Maru transforms the nebulizer experience for child asthma patients and their parents, by combining advanced technology with major usability improvements. The child-friendly design features an interactive interface that engages children during treatment sessions and promotes correct inhalation technique. The Maru ecosystem supports parents with guidance for independent home use. Maru enhances child cooperation while simultaneously reassuring parents and caregivers; creating a more enjoyable and effective treatment experience for families.
Client / ManufacturerDesign
AstraZeneca
North Carolina, US
Cambridge Consultants
Cambridge, GBAdam Haynes, Richard Mann, Chris Harm, Harry Moorman, Isaac Lee, James Ward, Andy Heidt, Lai Chiu TangDate of Launch
unknown
Development Time
up to 6 Month
Target Regions
Asia, Europe, North America
Target Groups
Consumers / Users, "Child asthma patients under 12 years old"